Literature DB >> 2354420

The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell lines.

C Welter1, W Henn, B Theisinger, H Fischer, K D Zang, N Blin.   

Abstract

The human c-myb gene which encodes a DNA binding protein and which is rarely amplified in neoplastic cells was found to be altered in four human glioblastoma cell lines. It exists in multiple copies in 2 out of 4 cases studied. The degree of amplification as determined by densitometry was about 10-fold, a rearrangement within the coding region and an enhanced gene activity of c-myb were noted. The observation of c-myb oncogene amplification and activity in glioblastoma cell lines presents the first report of this effect in human brain tumor cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354420     DOI: 10.1016/0304-3835(90)90077-b

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

2.  Infrequency of p53 gene mutations in ependymomas.

Authors:  K L Fink; E J Rushing; S C Schold; P D Nisen
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

3.  Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma.

Authors:  Michal Tichý; Lucia Knopfová; Jiří Jarkovský; Lucie Pekarčíková; Lenka Veverková; Petr Vlček; Jana Katolická; Ivan Čapov; Markéta Hermanová; Jan Šmarda; Petr Beneš
Journal:  Tumour Biol       Date:  2016-02-12

4.  Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis.

Authors:  Purvaba J Sarvaiya; Jason R Schwartz; Claudia P Hernandez; Paulo C Rodriguez; Wayne V Vedeckis
Journal:  Am J Hematol       Date:  2012-07-05       Impact factor: 10.047

Review 5.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

6.  Adult IDH wild-type lower-grade gliomas should be further stratified.

Authors:  Abudumijit Aibaidula; Aden Ka-Yin Chan; Zhifeng Shi; Yanxi Li; Ruiqi Zhang; Rui Yang; Kay Ka-Wai Li; Nellie Yuk-Fei Chung; Yu Yao; Liangfu Zhou; Jinsong Wu; Hong Chen; Ho-Keung Ng
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

7.  Brucine inhibits proliferation of glioblastoma cells by targeting the G-quadruplexes in the c-Myb promoter.

Authors:  Qiaochu Liu; Qunhui Wang; Chuanqi Lv; Ziqiang Liu; Haijun Gao; Yong Chen; Gang Zhao
Journal:  J Cancer       Date:  2021-02-02       Impact factor: 4.207

8.  Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.

Authors:  Eduarda P Martins; Céline S Gonçalves; Marta Pojo; Rita Carvalho; Ana S Ribeiro; Vera Miranda-Gonçalves; Ricardo Taipa; Fernando Pardal; Afonso A Pinto; Carlos Custódia; Cláudia C Faria; Fátima Baltazar; Nuno Sousa; Joana Paredes; Bruno M Costa
Journal:  Mol Oncol       Date:  2022-06-10       Impact factor: 7.449

9.  Alu elements mediate MYB gene tandem duplication in human T-ALL.

Authors:  Jennifer O'Neil; Joelle Tchinda; Alejandro Gutierrez; Lisa Moreau; Richard S Maser; Kwok-Kin Wong; Wei Li; Keith McKenna; X Shirley Liu; Bin Feng; Donna Neuberg; Lewis Silverman; Daniel J DeAngelo; Jeffery L Kutok; Rodney Rothstein; Ronald A DePinho; Lynda Chin; Charles Lee; A Thomas Look
Journal:  J Exp Med       Date:  2007-12-10       Impact factor: 14.307

10.  Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.

Authors:  H E Hirvonen; R Salonen; M M Sandberg; E Vuorio; I Västrik; E Kotilainen; H Kalimo
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.